CG
LEGN icon

Cutler Group’s Legend Biotech LEGN Stock Holding History

Cutler Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$7K Buy
+1,300
New +$78.4K ﹤0.01% 1436
2023
Q4 		– Sell
-2,500
Closed -$8K – 4009
2023
Q3 		$8K Buy
+2,500
New +$174K ﹤0.01% 2602
2022
Q2 		– Sell
-8,600
Closed -$5K – 5357
2022
Q1 		$5K Buy
+8,600
New +$340K ﹤0.01% 4138

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Cutler Group's LEGN Position: Q1 2024 in Review

Cutler Group opened a new position in Legend Biotech (LEGN) in Q1 2024: 1,900 shares worth $106K. The stake represents 0.03% of the portfolio and ranks #437 among its holdings. This is a return to the name: Cutler Group previously reported a position in LEGN as recently as Q4 2022.

Cutler Group first reported a position in LEGN in Q1 2022 and has held it in 3 quarters since. 192 funds tracked by Wall St. Rank hold LEGN as of Q1 2024.

  • Cutler Group held 1,900 shares of Legend Biotech worth $106K as of Q1 2024.
  • Legend Biotech was a new Cutler Group position in Q1 2024.
  • Legend Biotech made up 0.03% of Cutler Group's portfolio in Q1 2024, its #437 holding.
  • Cutler Group first reported a position in Legend Biotech in Q1 2022 and has held it in 3 quarters since.
  • 192 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.